|
|
|
|
|
|
|
|
|
|
|
|
|
24.02.26 - 23:24
|
Alcon setzt auf weiteres profitables Wachstum (Cash)
|
|
|
- Der Augenheilmittel-Konzern Alcon hat im vergangenen Jahr in neue Produkte investiert und will im neu angelaufenen Jahr von diesen Investitionen profitieren. Das Wachstum soll weiter beschleunigt und die Profitabilität klar verbessert werden, so die Zielsetzung....
|
|
|
24.02.26 - 23:18
|
Alcon Inc. Q4 Profit Falls (AFX)
|
|
|
BRUSSELS (dpa-AFX) - Alcon Inc. (ALC) released earnings for fourth quarter that Drops, from last yearThe company's bottom line came in at $217 million, or $0.44 per share. This compares with $284 ......
|
|
|
24.02.26 - 22:36
|
Alcon Delivers Strong Fourth-Quarter 2025 Topline Growth as New Product Launches Accelerate Sales (Business Wire)
|
|
|
Fourth-quarter 2025 sales of $2.7 billion, up 9% on a reported basis, or up 7% constant currency1 (cc), versus fourth-quarter 2024
Fourth-quarter 2025 diluted EPS of $0.44; core diluted EPS2 of $0.78
Generated $2.3 billion of cash from operations and $1.7 billion of free cash flow3 in full-year 2025
Returned $848 million to shareholders through share repurchases and dividends
Ad Hoc Announcement Pursuant to Art. 53 LRGENEVA--(BUSINESS WIRE)--Regulatory News:
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three and twelve month periods ending December 31, 2025. For the fourth quarter of 2025, sales were $2.7 billion, up 9% on a reported basis and up 7% on a constant currency basis1, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.44 and core diluted earnings per share2 of $0.78 in the fourth quarter of 2025.
"2025 was a pivotal and productive year for Alcon. Despite softer markets, we successfully launch...
|
|
|
|
|
|
|
23.02.26 - 14:06
|
Ausblick Alcon: Wachstumsbeschleunigung im Schlussquartal erwartet (Cash)
|
|
|
- Alcon dürfte sich zum Jahresende 2025 in einem von Herausforderungen geprägten Umfeld gut entwickelt haben. Analysten rechnen im gedämpften Konsumumfeld mit US-Zöllen als weiterer Hürde gar mit einer Wachstumsbeschleunigung. Im laufenden Jahr will Alcon mit zahlreichen Produkteinführung punkten....
|
|
|
|
|
|
|
|
|
21.01.26 - 06:13
|
Alcon beendet Aktienrückkauf (Cash)
|
|
|
Augenheilkunde - Alcon hat das im vergangenen April gestartete Aktienrückkaufprogramm im Umfang von 750 Millionen Dollar beendet....
|
|
|
20.01.26 - 22:36
|
Alcon Completes $750 Million Share Repurchase Program (Business Wire)
|
|
|
GENEVA--(BUSINESS WIRE)--Alcon Inc., the global leader in eye care dedicated to helping people see brilliantly, today announced the completion of its $750 million share repurchase program, which commenced on April 1, 2025.
In aggregate, 9,301,877 registered shares were acquired on the SIX Swiss Exchange, representing 1.9% of the current share capital of Alcon Inc. The total buyback volume amounted to CHF 602 million (USD 750 million).
The registered shares acquired will be held in treasury and are intended to offset the dilutive effect of registered shares vesting under Alcon's equity-based incentive plans.
About Alcon
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people's lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refra...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
